These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21725814)

  • 41. Ultrasonication-assisted preparation and characterization of emulsions and emulsion gels for topical drug delivery.
    Singh VK; Behera B; Pramanik K; Pal K
    J Pharm Sci; 2015 Mar; 104(3):1035-44. PubMed ID: 25470664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solvent exchange-induced in situ forming gel comprising ethyl cellulose-antimicrobial drugs.
    Phaechamud T; Mahadlek J
    Int J Pharm; 2015 Oct; 494(1):381-92. PubMed ID: 26302862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and evaluation of metronidazole acid gel for vaginal contraception.
    El-Gizawy SA; Aglan NI
    J Pharm Pharmacol; 2003 Jul; 55(7):903-9. PubMed ID: 12906747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter?
    Yoo J; Reid DC; Kimball AB
    J Drugs Dermatol; 2006 Apr; 5(4):317-9. PubMed ID: 16673797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled release of metronidazole benzoate from poly epsilon-caprolactone electrospun nanofibers for periodontal diseases.
    Zamani M; Morshed M; Varshosaz J; Jannesari M
    Eur J Pharm Biopharm; 2010 Jun; 75(2):179-85. PubMed ID: 20144711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical metronidazole: a new therapy for rosacea.
    Schmadel LK; McEvoy GK
    Clin Pharm; 1990 Feb; 9(2):94-101. PubMed ID: 2137747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical metronidazole therapy for rosacea.
    Bleicher PA; Charles JH; Sober AJ
    Arch Dermatol; 1987 May; 123(5):609-14. PubMed ID: 2953312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-situ gel formulations of econazole nitrate: preparation and in-vitro and in-vivo evaluation.
    Baloglu E; Karavana SY; Senyigit ZA; Hilmioglu-Polat S; Metin DY; Zekioglu O; Guneri T; Jones DS
    J Pharm Pharmacol; 2011 Oct; 63(10):1274-82. PubMed ID: 21899542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual controlled release, in situ gelling periodontal sol of metronidazole benzoate and serratiopeptidase: statistical optimization and mechanistic evaluation.
    Kumari N; Pathak K
    Curr Drug Deliv; 2012 Jan; 9(1):74-84. PubMed ID: 22023207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.
    Czernielewski J; Liu Y
    Arch Dermatol; 2004 Oct; 140(10):1282-3; author reply 1283. PubMed ID: 15492198
    [No Abstract]   [Full Text] [Related]  

  • 52. Innovative use of topical metronidazole.
    Zip CM
    Dermatol Clin; 2010 Jul; 28(3):525-34. PubMed ID: 20510762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
    Leyden JJ
    J Drugs Dermatol; 2011 Oct; 10(10):1179-85. PubMed ID: 21968669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of topical metronidazole in the treatment of rosacea.
    Wolf JE
    Cutis; 2004 Jan; 73(1 Suppl):19-28. PubMed ID: 14959942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethoxysilane-capped PEO-PPO-PEO triblocks: a new family of reverse thermo-responsive polymers.
    Sosnik A; Cohn D
    Biomaterials; 2004 Jun; 25(14):2851-8. PubMed ID: 14962563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration.
    Perioli L; Pagano C; Mazzitelli S; Rossi C; Nastruzzi C
    Int J Pharm; 2008 May; 356(1-2):19-28. PubMed ID: 18258393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%.
    Elewski BE
    Cutis; 2007 Jan; 79(1):57-8; author reply 58. PubMed ID: 17330623
    [No Abstract]   [Full Text] [Related]  

  • 58. Topical metronidazole combination therapy in the clinical management of rosacea.
    Del Rosso JQ; Bikowski J
    J Drugs Dermatol; 2005; 4(4):473-80. PubMed ID: 16004021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base.
    Baloglu E; Karavana SY; Senyigit ZA; Guneri T
    Pharm Dev Technol; 2011; 16(6):627-36. PubMed ID: 20715905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties.
    Bruschi ML; Jones DS; Panzeri H; Gremião MP; de Freitas O; Lara EH
    J Pharm Sci; 2007 Aug; 96(8):2074-89. PubMed ID: 17301966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.